glp 1 l cells glp-1 secretion GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation β Cell GLP-1R Signaling Alters

Together, these actions reduce appetite, improve metabolism, and support weight loss

Using degraded medication may result in: Suboptimal blood glucose control in patients with type 2 diabetes Reduced weight loss efficacy for those using GLP-1 agonists for weight management Unpredictable dosing , as degradation may be partial rather than complete Patients with diabetes who suspect reduced medication efficacy should monitor their blood glucose more frequently and contact their GP or diabetes care team if they have concerns about medication storage or if their diabetes control deteriorates unexpectedly

Thnh phn Glutathione l g

2.4 Dialysis of MDH The apo form of MDH was obtained by EDTA treatment

Authors: James Park, 3rd Year Student Pharmacist at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences